Valuation: GENFIT

Market Cap 687M 784M 637M 586M 1.11B 75B 1.13B 7.59B 2.98B 36.83B 2.94B 2.88B 127B P/E 2026 *
72.3x
P/E 2027 * 91.2x
Enterprise Value 636M 725M 589M 542M 1.03B 69.43B 1.05B 7.02B 2.75B 34.09B 2.72B 2.66B 118B EV / Sales 2026 *
6.35x
EV / Sales 2027 * 5.01x
Free-Float
86.88%
Yield 2026 *
-
Yield 2027 * -
1 day-1.75%
1 week+0.75%
Current month+27.36%
1 month+39.32%
3 months+53.41%
6 months+155.44%
Current year+156.41%
1 week 12.94
Extreme 12.94
14.32
1 month 9
Extreme 9
14.32
Current year 5.05
Extreme 5.05
14.32
1 year 3.05
Extreme 3.048
14.32
3 years 2.62
Extreme 2.62
14.32
5 years 2.62
Extreme 2.62
14.32
10 years 2.62
Extreme 2.62
35.65
Manager TitleAgeSince
Chief Executive Officer 58 15/09/2019
Director of Finance/CFO 52 21/04/2021
Chief Tech/Sci/R&D Officer - 26/11/2025
Director TitleAgeSince
Chairman 70 15/06/2017
Director/Board Member 54 14/09/1999
Director/Board Member 58 15/06/2017
Date Insider Type Main position Quantity % Market Cap.
03-04Sell

Chief Operating Officer

10,625 0.0212%
03-04Fiscal year

Chief Operating Officer

11,250 0.0225%
03-04Sell

Chief Operating Officer

7,083 0.0142%
Change 5-day change 1-year change 3-year change Capi.($)
-1.75%+0.75%+314.62%+262.90% 786M
+0.44%+1.41%+4.25%+10.81% 50.73B
-2.81%-4.54%+372.69%+583.64% 39.73B
+0.90%+1.82%+30.96%-4.52% 34.69B
+1.79%-2.08%+20.18%+52.91% 33.21B
-0.06%-4.63%+2.94%+31.65% 26.76B
-2.04%-1.32% - - 16.8B
-0.90%-5.59%+66.53%+121.90% 15.37B
+0.78%+1.16%+15.53%+17.32% 13.78B
-0.58%-2.11%+11.92%-32.79% 12.85B
Average -0.43%-0.26%+93.29%+115.98% 24.47B
Weighted average by Cap. -0.21%-0.36%+81.10%+123.22%

Financials

2026 *2027 *
Net sales 100M 114M 92.8M 85.39M 162M 10.93B 165M 1.11B 434M 5.37B 429M 420M 18.54B 124M 141M 115M 106M 200M 13.54B 204M 1.37B 537M 6.65B 531M 519M 22.96B
Net income 22.88M 26.08M 21.19M 19.5M 36.88M 2.5B 37.59M 253M 99.05M 1.23B 97.95M 95.81M 4.23B 6.8M 7.75M 6.3M 5.79M 10.96M 742M 11.17M 75.06M 29.44M 364M 29.11M 28.48M 1.26B
Net Debt -51.12M -58.28M -47.34M -43.56M -82.4M -5.58B -84M -564M -221M -2.74B -219M -214M -9.46B -66.17M -75.45M -61.29M -56.39M -107M -7.22B -109M -730M -286M -3.55B -283M -277M -12.25B
Logo GENFIT
GENFIT is a biopharmaceutical company in late-stage development focused on the discovery and development of innovative therapeutic and diagnostic solutions in the field of liver diseases, particularly of metabolic origin, where unmet medical needs are considerable, in particular due to a lack of approved treatments. GENFIT is a leading innovator in the field of nuclear receptor-based drug discovery with a rich history and a solid scientific heritage spanning nearly two decades. The company has offices in Lille, Paris, Zurich and Cambridge, MA (USA).
Employees
161
Date Price Change Volume
13/07/26 13.50 -1.75% 610,685
10/07/26 €13.74 -0.29% 345,417
09/07/26 €13.78 +0.15% 426,540
08/07/26 €13.76 +2.23% 604,656
07/07/26 €13.46 +0.45% 433,512
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
13.74EUR
Average target price
15.90EUR
Spread / Average Target
+15.72%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. GNFT Stock